• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一组潜在的益生菌菌株以剂量和性别依赖的方式改变了Wistar大鼠的肠道微生物群。

A Mix of Potentially Probiotic Strains Alters the Gut Microbiota in a Dose- and Sex-Dependent Manner in Wistar Rats.

作者信息

Carneiro Dos Santos Lucas Alves, Carvalho Rodrigo Dias de Oliveira, Cruz Neto José Patrocínio Ribeiro, de Albuquerque Lemos Deborah Emanuelle, de Oliveira Kataryne Árabe Rimá, Sampaio Karoliny Brito, de Luna Freire Micaelle Oliveira, Aburjaile Flavia Figueira, Azevedo Vasco Ariston de Carvalho, de Souza Evandro Leite, de Brito Alves José Luiz

机构信息

Department of Nutrition, Health Sciences Center, Federal University of Paraíba, João Pessoa 58051-900, Brazil.

Department of Genetics, Ecology and Evolution, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.

出版信息

Microorganisms. 2024 Mar 26;12(4):659. doi: 10.3390/microorganisms12040659.

DOI:10.3390/microorganisms12040659
PMID:38674604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11052373/
Abstract

Multi-strain (L.) is a potential probiotic with reported immunomodulatory properties. This study aimed to evaluate the composition, richness, and diversity of the gut microbiota in male and female rats after treatment with a multi-strain of at different doses. Thirty rats (fifteen male and fifteen female) were allocated into a control group (CTL), a group receiving at a dose of 10 CFU (Lf-10), and a group receiving at a dose of 10 CFU (Lf-10) for 13 weeks. Gut microbiota and serum cytokine levels were evaluated after treatment. Male CTL rats had a lower relative abundance of and and a lower alpha diversity than their female CTL counterparts ( < 0.05). In addition, male CTL rats had a higher (F/B) ratio than female CTL rats ( < 0.05). In female rats, the administration of at 10 CFU decreased the relative abundance of and and increased ( < 0.05). In male rats, the administration of at 10 CFU decreased the F/B ratio and increased and the diversity of the gut microbiota ( < 0.05). The relative abundance of and the alpha-diversity of gut microbiota were negatively correlated with serum levels of IL1β (r = -0.44) and TNFα (r = -0.39), respectively. This study identified important changes in gut microbiota between male and female rats and showed that a lower dose of may have more beneficial effects on gut microbiota in females, while a higher dose may result in more beneficial effects on gut microbiota in male rats.

摘要

多菌株(L.)是一种据报道具有免疫调节特性的潜在益生菌。本研究旨在评估不同剂量多菌株处理后雄性和雌性大鼠肠道微生物群的组成、丰富度和多样性。将30只大鼠(15只雄性和15只雌性)分为对照组(CTL)、接受10⁸CFU剂量的一组(Lf-10)和接受10¹⁰CFU剂量的一组(Lf-10),处理13周。处理后评估肠道微生物群和血清细胞因子水平。雄性CTL大鼠的[具体菌属1]和[具体菌属2]相对丰度低于雌性CTL大鼠,且α多样性较低(P<0.05)。此外,雄性CTL大鼠的[某比值](F/B)高于雌性CTL大鼠(P<0.05)。在雌性大鼠中,给予10⁸CFU的[多菌株名称]降低了[具体菌属3]和[具体菌属4]的相对丰度,并增加了[某比值](P<0.05)。在雄性大鼠中,给予10¹⁰CFU的[多菌株名称]降低了F/B比值,并增加了[具体菌属5]和肠道微生物群的多样性(P<0.05)。肠道微生物群的[具体菌属6]相对丰度和α多样性分别与血清IL1β水平(r=-0.44)和TNFα水平(r=-0.39)呈负相关。本研究确定了雄性和雌性大鼠肠道微生物群的重要变化,并表明较低剂量的[多菌株名称]可能对雌性肠道微生物群有更有益的影响,而较高剂量可能对雄性大鼠肠道微生物群产生更有益的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c5/11052373/20d6a36da088/microorganisms-12-00659-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c5/11052373/837156c032fc/microorganisms-12-00659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c5/11052373/aef5acaba9b4/microorganisms-12-00659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c5/11052373/252f82575f1a/microorganisms-12-00659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c5/11052373/f386a1885e61/microorganisms-12-00659-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c5/11052373/20d6a36da088/microorganisms-12-00659-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c5/11052373/837156c032fc/microorganisms-12-00659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c5/11052373/aef5acaba9b4/microorganisms-12-00659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c5/11052373/252f82575f1a/microorganisms-12-00659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c5/11052373/f386a1885e61/microorganisms-12-00659-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c5/11052373/20d6a36da088/microorganisms-12-00659-g005.jpg

相似文献

1
A Mix of Potentially Probiotic Strains Alters the Gut Microbiota in a Dose- and Sex-Dependent Manner in Wistar Rats.一组潜在的益生菌菌株以剂量和性别依赖的方式改变了Wistar大鼠的肠道微生物群。
Microorganisms. 2024 Mar 26;12(4):659. doi: 10.3390/microorganisms12040659.
2
Potentially Probiotic Limosilactobacillus fermentum Fruit-Derived Strains Alleviate Cardiometabolic Disorders and Gut Microbiota Impairment in Male Rats Fed a High-Fat Diet.具有潜在益生菌特性的发酵乳杆菌水果源菌株可缓解高脂饮食雄性大鼠的心脏代谢紊乱和肠道微生物群损伤
Probiotics Antimicrob Proteins. 2022 Apr;14(2):349-359. doi: 10.1007/s12602-021-09889-y. Epub 2022 Jan 23.
3
Oral administration of Lactobacillus fermentum post-weaning improves the lipid profile and autonomic dysfunction in rat offspring exposed to maternal dyslipidemia.断奶后口服发酵乳杆菌可改善母代脂代谢异常大鼠子代的血脂谱和自主神经功能障碍。
Food Funct. 2020 Jun 24;11(6):5581-5594. doi: 10.1039/d0fo00514b.
4
Limosilactobacillus fermentum Strains with Claimed Probiotic Properties Exert Anti-oxidant and Anti-inflammatory Properties and Prevent Cardiometabolic Disorder in Female Rats Fed a High-Fat Diet.具有声称的益生菌特性的发酵乳杆菌菌株具有抗氧化和抗炎特性,并可预防高脂肪饮食喂养的雌性大鼠的代谢综合征。
Probiotics Antimicrob Proteins. 2023 Jun;15(3):601-613. doi: 10.1007/s12602-021-09878-1. Epub 2021 Nov 24.
5
Safety Evaluation of a Novel Potentially Probiotic Limosilactobacillus fermentum in Rats.新型潜在益生菌发酵乳杆菌的大鼠安全性评价。
Probiotics Antimicrob Proteins. 2024 Jun;16(3):752-762. doi: 10.1007/s12602-023-10077-3. Epub 2023 Apr 29.
6
FM9 and Y57 Are as Effective as Statins at Improving Blood Lipid Profile in High Cholesterol, High-Fat Diet Model in Male Wistar Rats.FM9 和 Y57 在改善雄性 Wistar 大鼠高胆固醇高脂肪饮食模型的血脂谱方面与他汀类药物同样有效。
Nutrients. 2022 Apr 15;14(8):1654. doi: 10.3390/nu14081654.
7
The probiotic Lactobacillus fermentum 296 attenuates cardiometabolic disorders in high fat diet-treated rats.发酵乳杆菌 296 可减轻高脂肪饮食大鼠的代谢综合征。
Nutr Metab Cardiovasc Dis. 2019 Dec;29(12):1408-1417. doi: 10.1016/j.numecd.2019.08.003. Epub 2019 Aug 14.
8
Lactobacillus sp. improved microbiota and metabolite profiles of aging rats.植物乳杆菌改善了衰老大鼠的微生物群和代谢物谱。
Pharmacol Res. 2019 Aug;146:104312. doi: 10.1016/j.phrs.2019.104312. Epub 2019 Jun 14.
9
Probiotic Lactobacillus fermentum strain JDFM216 improves cognitive behavior and modulates immune response with gut microbiota.益生菌发酵乳杆菌 JDFM216 通过肠道微生物群改善认知行为和调节免疫反应。
Sci Rep. 2020 Dec 10;10(1):21701. doi: 10.1038/s41598-020-77587-w.
10
Lactobacillus fermentum CECT5716 supplementation in rats during pregnancy and lactation affects mammary milk composition.妊娠和哺乳期大鼠补充发酵乳杆菌 CECT5716 会影响乳腺乳汁成分。
J Dairy Sci. 2020 Apr;103(4):2982-2992. doi: 10.3168/jds.2019-17384. Epub 2020 Jan 31.

引用本文的文献

1
Thermal and storage stability of novel nutraceuticals combining potential probiotic Limosilactobacillus fermentum strains and freeze-dried jabuticaba [Myrciaria cauliflora (Mart.) O. Berg] peel.新型营养保健品的热稳定性和储存稳定性——结合潜在益生菌发酵乳杆菌菌株与冻干巴西红果[光叶巴西番荔枝(马尔特)O. 伯格]果皮
Braz J Microbiol. 2025 Mar;56(1):23-38. doi: 10.1007/s42770-024-01576-8. Epub 2024 Dec 2.

本文引用的文献

1
Limosilactobacillus fermentum Strains as Novel Probiotic Candidates to Promote Host Health Benefits and Development of Biotherapeutics: A Comprehensive Review.发酵乳杆菌菌株作为促进宿主健康益处和生物治疗发展的新型益生菌候选物:全面综述。
Probiotics Antimicrob Proteins. 2024 Aug;16(4):1483-1498. doi: 10.1007/s12602-024-10235-1. Epub 2024 Feb 23.
2
Effects of Probiotic-Enriched Minas Cheese (Lactobacillus acidophilus La-05) on Cardiovascular Parameters in 5/6 Nephrectomized Rats.富含益生菌的米纳斯奶酪(嗜酸乳杆菌La-05)对5/6肾切除大鼠心血管参数的影响。
Probiotics Antimicrob Proteins. 2025 Apr;17(2):873-887. doi: 10.1007/s12602-023-10173-4. Epub 2023 Nov 2.
3
Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota.
短链脂肪酸产生菌:人类肠道微生物群的关键组成部分。
Nutrients. 2023 May 6;15(9):2211. doi: 10.3390/nu15092211.
4
Ischaemic stroke patients present sex differences in gut microbiota.缺血性中风患者的肠道微生物群存在性别差异。
Eur J Neurol. 2023 Nov;30(11):3497-3506. doi: 10.1111/ene.15931. Epub 2023 Jul 1.
5
Gut bacteria and sex differences in colorectal cancer.肠道细菌与结直肠癌的性别差异。
J Med Microbiol. 2023 Jun;72(6). doi: 10.1099/jmm.0.001706.
6
Safety Evaluation of a Novel Potentially Probiotic Limosilactobacillus fermentum in Rats.新型潜在益生菌发酵乳杆菌的大鼠安全性评价。
Probiotics Antimicrob Proteins. 2024 Jun;16(3):752-762. doi: 10.1007/s12602-023-10077-3. Epub 2023 Apr 29.
7
Sex Differences in Association Between Gut Microbiome and Essential Hypertension Based on Ambulatory Blood Pressure Monitoring.基于动态血压监测的肠道微生物组与原发性高血压的性别差异关联。
Hypertension. 2023 Jun;80(6):1331-1342. doi: 10.1161/HYPERTENSIONAHA.122.20752. Epub 2023 Apr 19.
8
Altered gut microbiota in patients with idiopathic Parkinson's disease: an age-sex matched case-control study.特发性帕金森病患者肠道微生物群的改变:一项年龄性别匹配的病例对照研究。
Acta Neurol Belg. 2023 Jun;123(3):999-1009. doi: 10.1007/s13760-023-02195-0. Epub 2023 Jan 31.
9
Effects of Simulated Gastrointestinal Conditions on Combined Potentially Probiotic Limosilactobacillus fermentum 296, Quercetin, and/or Resveratrol as Bioactive Components of Novel Nutraceuticals.模拟胃肠道条件对新型营养保健品中组合潜在益生菌发酵乳杆菌 296、槲皮素和/或白藜芦醇等生物活性成分的影响。
Probiotics Antimicrob Proteins. 2024 Feb;16(1):308-319. doi: 10.1007/s12602-023-10046-w. Epub 2023 Jan 28.
10
High levels of are associated with the pathogenesis of Parkinson's disease.高水平的[具体物质未给出]与帕金森病的发病机制有关。
Front Integr Neurosci. 2023 Jan 4;16:1054627. doi: 10.3389/fnint.2022.1054627. eCollection 2022.